Skip to content

Bio Wink: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Bio Wink

BE 0736.308.291
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€11,659
2024 · €48,576-€36,917
Equity
€38,779
2024 · €27,620+€11,159
Cash
€15,935
2024 · €69,802-€53,866
Balance sheet total
€106,514
2024 · €222,448-€115,934

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€58,909

    down €58,909 (-57.9%), from €101,678 to €42,769

    of which Trade receivables: -€67,909

  • Cash -€53,866

    down €53,866 (-77.2%), from €69,802 to €15,935

    mainly Trade debts (-€78,034) and Other debts (-€49,050)

  • Tangible fixed assets -€2,600

    no longer reported in 2025 (was €2,600)

Equity and liabilities
  • Trade debts -€78,034

    down €78,034 (-83.4%), from €93,587 to €15,553

  • Other debts -€49,050

    down €49,050 (-52.0%), from €94,396 to €45,346

  • Profit (loss) carried forward +€11,659

    up €11,659 (+128%), from €9,120 to €20,779

Income statement
  • Gross operating margin -€35,930

    down €35,930 (-62.0%), from €57,907 to €21,977

  • Financial charges +€1,818

    up €1,818 (+4,811%), from €38 to €1,856

  • Taxes -€971

    down €971 (-18.2%), from €5,338 to €4,367

  • Other operating charges +€692

    up €692 (+85.5%), from €810 to €1,502

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €48,576
Gross operating margin -€35,930
Depreciation +€423
Write-downs +€122
Other operating charges -€692
Financial income +€8
Financial charges -€1,818
Taxes +€971
Result 2025 €11,659
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€53,366
Investment €0
Financing -€500
Cash 2024 €69,802
Net result for the year +€11,659
Depreciation +€2,600
Stocks and contracts +€559
Receivables within one year +€58,909
Trade debts -€78,034
Tax, wage and social debts -€10
Other debts -€49,050
Contributions, distributions and other -€500
Cash 2025 €15,935
brings cash intakes cash out
Every line side by side 35 lines
Line Code 2024 2025 Change %
Total assets 20/58 €222,448 €106,514 -€115,934 -52.1%
Fixed assets 21/28 €2,600 - -€2,600
Tangible fixed assets 22/27 €2,600 - -€2,600
Plant, machinery and equipment 23 €2,600 - -€2,600
Current assets 29/58 €219,848 €106,514 -€113,334 -51.6%
Stocks and contracts in progress 3 €48,369 €47,810 -€559 -1.2%
Stocks 30/36 €48,369 €47,810 -€559 -1.2%
Amounts receivable within one year 40/41 €101,678 €42,769 -€58,909 -57.9%
Trade receivables 40 €99,615 €31,705 -€67,909 -68.2%
Other amounts receivable 41 €2,063 €11,063 +€9,000 +436%
Cash at bank and in hand 54/58 €69,802 €15,935 -€53,866 -77.2%
Total equity and liabilities 10/49 €222,448 €106,514 -€115,934 -52.1%
Equity 10/15 €27,620 €38,779 +€11,159 +40.4%
Contributions 10/11 €18,500 €18,000 -€500 -2.7%
Profit (loss) carried forward 14 €9,120 €20,779 +€11,659 +128%
Amounts payable 17/49 €194,828 €67,735 -€127,094 -65.2%
Amounts payable within one year 42/48 €194,828 €67,735 -€127,094 -65.2%
Trade debts 44 €93,587 €15,553 -€78,034 -83.4%
Suppliers 440/4 €93,587 €15,553 -€78,034 -83.4%
Taxes, remuneration and social security 45 €6,846 €6,836 -€10 -0.1%
Taxes 450/3 €6,846 €6,836 -€10 -0.1%
Other amounts payable 47/48 €94,396 €45,346 -€49,050 -52.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €3,023 €2,600 -€423 -14.0%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €122 - -€122
Other operating charges 640/8 €810 €1,502 +€692 +85.5%
Gross operating margin 9900 €57,907 €21,977 -€35,930 -62.0%
Operating profit (loss) 9901 €53,952 €17,875 -€36,077 -66.9%
Financial income 75/76B €0 €8 +€8 +2,312%
Recurring financial income 75 €0 €8 +€8 +2,312%
Financial charges 65/66B €38 €1,856 +€1,818 +4,811%
Recurring financial charges 65 €38 €1,856 +€1,818 +4,811%
Profit (loss) for the period before taxes 9903 €53,914 €16,027 -€37,887 -70.3%
Income taxes 67/77 €5,338 €4,367 -€971 -18.2%
Profit (loss) for the period 9904 €48,576 €11,659 -€36,917 -76.0%
Profit (loss) for the period to be appropriated 9905 €48,576 €11,659 -€36,917 -76.0%

Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.